Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
Early White Matter Changes in Childhood Multiple Sclerosis: A Diffusion Tensor Imaging Study.
Oxidative stress-dependent phosphorylation activates ZNRF1 to induce neuronal/axonal degeneration.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
Neurobehavioral burden of multiple sclerosis with nanotheranostics.
Clinical trials in multiple sclerosis.
Therapeutic effects of anti-Delta1 mAb on Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Saffold cardiovirus and multiple sclerosis: no evidence for an association.
Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1000 Genomes Project.
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
The relationship between muscle pain and fatigue.
A role for human brain pericytes in neuroinflammation.
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility.
Treatment of relapsing-remitting multiple sclerosis: current and future algorithms.
Subacute CNS demyelination after treatment with nivolumab for melanoma.
Immune reconstitution inflammatory syndrome and natalizumab-Is it possible before removing the drug?
Multiple sclerosis in the Southern and Northern hemispheres: the month of birth at different latitudes has the same influence on the prevalence and progression of the disease in the Northern and Southern hemispheres?
The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.
Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
Vitamin D supplementation, moderate sun exposure, and control of immune Diseases.
Adherence to monthly online self-assessments for short-term monitoring: a 1-year study in relapsing-remitting multiple sclerosis patients after start of disease modifying treatment.
Retinal Damage and Vision Loss in African-American Multiple Sclerosis Patients.
Pages
« first
‹ previous
…
381
382
383
384
385
386
387
388
389
…
next ›
last »